Skip to main content
SpringerLink
Log in

Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Göllner S, Oellerich T, Agrawal-Singh S, Schenk T, Klein H-U, Rohde C, et al. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia. Nat Med. 2017;23:69–78.

    Article  PubMed  Google Scholar 

  2. Kikuchi J, Koyama D, Wada T, Izumi T, Hofgaard PO, Bogen B, Furukawa Y. Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. J Clin Investig. 2015;125:4375–90.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med. 2003;9:1158–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT, a Grant-in-Aid for Scientific Research from JSPS, and research Grants from the Japan Leukemia Research Fund, Yasuda Memorial Cancer Foundation, Takeda Science Foundation, Novartis Foundation (to JK and YF), Mitsui Life Social Welfare Foundation and SENSHIN Medical Research Foundation (to JK). JK and YF received the Kano Foundation Research Grant and the Kobayashi Foundation Cancer Research Award, respectively.

Author information

Authors and Affiliations

  1. Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical School, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Jiro Kikuchi, Yoshiaki Kuroda, Daisuke Koyama & Yusuke Furukawa

Authors
  1. Jiro Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshiaki Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daisuke Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yusuke Furukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yusuke Furukawa.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 54 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kikuchi, J., Kuroda, Y., Koyama, D. et al. Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells. Int J Hematol 107, 383–385 (2018). https://doi.org/10.1007/s12185-017-2376-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-017-2376-0

Search

Navigation